Exact Sciences Corporation
Exact Sciences Corporation
EXAS
Valuace
85
Růst
75
Zdraví
75
Cena
$ 66.56
Dnes
+0.09 (0.09%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
12.6B
Obrat
3B
Zisk
0B
Aktiva
6B
Dluh
3B
ROE
0%
ROA
0%
PE
-96
PS
6
Cena 1R
39-103
⌀ Cena
62.83
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
18-02-2026
Poslední dividenda

Profil

Společnost Exact Sciences Corporation poskytuje screening rakoviny a diagnostické testovací produkty ve Spojených státech a mezinárodně. Společnost nabízí Cologuard, neinvazivní stoliční DNA screeningový test pro detekci DNA a hemoglobinových biomarkerů spojených s kolorektálním karcinomem a prekancerózou. Poskytuje také Oncotype DX, test exprese genů pro rakovinu prsu, prostaty a tlustého střeva; Oncotype Test, tkáňový test poskytující profilaci nádoru pro usnadnění výběru terapie u pacientů s pokročilým, metastazujícím, refrakterním nebo rekurentním karcinomem; Oncotype DX AR-V7 Nucleus Detect Test, test založený na tekutině pro pokročilé stadium karcinomu prostaty; Oncomap ExTra, který poskytuje kompletní biologický obraz některých refrakterních, vzácných nebo agresivních karcinomů; a testování na covid-19. Výrobky ropovodu společnosti se zaměřují na zlepšení výkonových charakteristik testu Cologuard a vývoj krevních a dalších tekutých testů. Má licenční smlouvy s nadací MAYO Foundation for Medical Education and Research a Hologic, Inc. Exact Sciences Corporation byla založena v roce 1995 a sídlí v Madisonu ve Wisconsinu.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
6900
Založení
2001-02-01
Adresa
5505 Endeavor Lane
CEO
Kevin T. Conroy

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues3,247.03,247.02,758.92,499.82,084.31,767.11,491.4876.3454.5266.099.439.41.84.14.14.25.3
Cost of Revenues984.2984.2840.2654.2574.4458.8354.3216.7118.079.245.224.54.30.00.00.00.0
Gross Profit2,262.82,262.81,918.71,845.51,509.91,308.31,137.1659.6336.5186.854.214.9-2.54.14.14.15.3
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues878.4850.7811.1706.8713.4708.7699.3637.5646.9628.3
Cost of Revenues262.6266.8248.6206.2284.2217.2210.9191.2171.8168.5
Gross Profit615.8583.9562.5500.5429.2491.5488.3446.3475.1459.8
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0425.9393.4385.6554.1139.768.242.133.533.928.727.742.122.09.0
Selling General & Admin Expenses0.00.00.01,620.31,583.31,663.21,071.6737.6427.7263.0189.7140.169.323.214.711.08.1
Depreciation & Amortization221.6221.6214.9206.697.595.093.416.023.115.611.57.83.71.41.00.40.2
Total Operating Expenses2,463.12,361.92,967.42,060.52,087.42,143.81,695.4893.4496.0305.1223.2174.098.050.956.833.017.1
Operating Income-200.4-99.1-1,048.7-215.0-577.5-835.5-558.4-233.8-159.5-118.3-169.0-159.1-100.5-46.8-52.6-28.8-11.8
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.0114.9111.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0411.0390.6
Depreciation & Amortization56.455.955.354.153.154.853.053.954.259.4
Total Operating Expenses692.5609.5564.6596.61,305.6530.9514.6553.0542.9453.0
Operating Income-76.7-25.5-2.1-96.0-876.4-39.4-26.3-106.7-67.86.8
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income7.942.70.0-5.40.00.00.00.00.00.00.00.00.00.30.30.20.0
Interest Expense36.632.932.024.419.618.696.061.636.80.20.20.00.10.10.00.00.0
Other Expense-3.5-104.812.513.3-55.0-7.0-298.8-35.121.23.92.01.30.50.30.30.10.2
IBT-203.9-203.9-1,036.2-201.7-632.6-842.5-857.1-268.9-175.1-114.6-167.2-157.8-100.0-46.5-52.4-28.7-11.6
Income Tax Expense4.14.1-7.32.4-9.1-246.9-8.6-184.90.1-0.2-11.3-7.7-3.7-1.0-0.70.0-0.3
Net Income-207.9-207.9-1,028.9-204.1-623.5-595.6-848.5-84.0-175.1-114.4-167.2-157.8-100.0-46.5-52.4-28.7-11.6
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income7.90.00.00.00.00.00.00.00.06,252.1
Interest Expense8.29.89.88.88.28.30.07.96.57.9
Other Expense-8.47.82.1-5.00.42.011.9-1.717.5-5.8
IBT-85.1-17.8-0.1-101.0-876.0-37.4-14.3-108.4-50.41.0
Income Tax Expense0.91.81.10.2-11.40.81.51.8-0.60.2
Net Income-86.0-19.6-1.2-101.2-864.6-38.2-15.8-110.2-49.80.8
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.13$-3.54$-3.48$-5.61$-0.64$-1.43$-0.99$-1.63$-1.71$-1.25$-0.69$-0.88$-0.55$-0.29
EPS Diluted$0.00$0.00$0.00$-1.13$-3.54$-3.48$-5.61$-0.64$-1.43$-0.99$-1.63$-1.71$-1.25$-0.69$-0.88$-0.55$-0.29
Shares Outstanding189.7188.7184.2180.1176.4171.3151.1131.3122.2115.7102.392.180.267.559.552.540.5
Diluted Shares Outstanding189.7188.7184.2180.1176.4171.3151.1131.3122.2115.7102.392.180.267.559.552.540.5
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.27$0.00
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.27$0.00
Shares Outstanding189.7189.3188.9186.8185.3184.8184.3182.4181.1180.6
Diluted Shares Outstanding189.7189.3188.9186.8185.3184.8184.3182.4181.1184.1
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents530.2600.9605.4242.5315.51,491.3177.3160.477.548.941.158.112.913.335.878.8
Short Term Investments416.6437.1172.3389.6715.0348.7146.4963.8347.2262.2265.7224.6120.494.857.616.7
Total Cash & ST Investments946.81,038.0777.6632.11,030.51,840.0323.71,124.2424.7311.1306.9282.8133.3108.193.495.4
Accounts Receivable268.1249.0203.6158.0216.6233.2130.744.226.48.54.91.40.00.00.00.0
Inventory127.4162.4127.5118.3105.092.361.739.126.06.86.74.00.00.00.00.0
Other Current Assets110.3122.085.673.974.133.240.920.510.17.17.63.52.20.61.00.2
Total Current Assets1,452.51,571.41,194.4982.31,426.22,198.6557.01,228.1487.2333.6326.1291.7135.5108.794.495.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents789.0657.1347.1600.9588.8530.2347.5605.4594.6604.4
Short Term Investments214.1201.3439.0437.1432.3416.6304.6172.3139.8171.3
Total Cash & ST Investments1,003.1858.4786.21,038.01,021.1946.8652.1777.6734.4775.7
Accounts Receivable306.1353.3279.8249.0264.8263.9240.6203.6199.4178.3
Inventory164.8171.5176.6162.4137.0127.4128.5127.5132.8130.8
Other Current Assets116.8124.6127.8122.0110.2114.599.185.681.589.1
Total Current Assets1,590.71,507.91,370.31,571.41,533.11,452.51,120.31,194.41,148.21,173.9
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment864.3810.6842.1851.8754.5576.6581.8245.380.038.134.119.911.23.42.60.9
Goodwill2,367.02,366.72,367.12,346.02,335.21,237.71,203.217.30.00.00.00.00.00.00.00.0
Intangible Assets1,843.51,009.71,890.41,956.22,094.4848.41,143.646.322.20.00.00.00.00.00.00.0
Long-Term Investments17.20.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets128.8169.7177.490.674.663.820.34.49.25.34.10.00.00.00.00.0
Total Long-Term Assets5,220.84,356.75,277.05,244.65,258.62,726.52,948.8296.0111.343.538.219.911.23.42.60.9
Total Assets6,673.35,928.16,471.36,226.96,684.94,925.13,505.81,524.0598.6377.0364.3311.6146.6112.197.096.5
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment838.0831.2824.6810.6812.8842.9844.1842.1842.1835.3
Goodwill2,368.02,368.02,367.12,366.72,367.52,367.02,367.12,367.12,366.52,346.2
Intangible Assets941.2965.4988.91,009.71,864.41,843.51,866.91,890.41,913.31,910.6
Long-Term Investments111.67.40.00.00.00.00.014.940.645.1
Other Long-Term Assets50.5117.5160.2169.7170.8167.5178.1-287.5150.789.5
Total Long-Term Assets4,309.34,289.54,340.74,356.75,215.55,220.85,256.15,277.05,272.65,181.6
Total Assets5,900.05,797.45,711.15,928.16,748.66,673.36,376.36,471.36,420.86,355.6
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable53.089.678.874.967.835.726.028.116.10.73.32.60.83.70.81.0
Short-Term Debt283.3276.679.428.419.7268.38.70.00.20.20.20.40.40.30.00.0
Other Current Liabilities332.3366.1356.5309.531.038.38.53.22.71.71.00.60.57.53.12.0
Current Liabilities668.6732.2514.7412.7517.1575.8236.5136.668.130.726.717.57.811.58.07.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable129.4157.3142.289.697.753.060.578.873.675.1
Short-Term Debt37.831.329.8276.6276.2276.0326.083.884.783.7
Other Current Liabilities417.2333.3330.5366.1349.8339.6298.6352.1318.3329.3
Current Liabilities584.3521.9502.5732.2723.7668.6685.1514.7476.5488.1
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt2,317.92,478.22,475.32,418.52,362.41,464.2946.3688.84.34.64.91.01.41.71.01.0
Capital Leases182.7184.5190.4182.4182.2121.1118.78.20.10.71.10.40.40.70.00.0
Def. Tax Liability19.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities3,480.93,525.93,326.03,183.73,297.22,101.61,217.7843.178.141.737.422.611.313.513.516.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt2,497.32,490.12,491.52,478.22,482.22,485.62,229.22,475.32,481.32,480.1
Capital Leases195.7197.4198.7184.5189.9182.7189.6190.4168.4168.5
Def. Tax Liability6.80.00.00.00.00.00.0467.318.719.8
Total Liabilities3,398.63,328.03,314.23,525.93,538.13,480.93,243.73,326.03,299.63,298.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock1.81.91.81.81.71.61.51.21.21.11.00.90.70.60.60.5
Retained Earnings-3,595.2-4,498.0-3,469.2-3,265.0-2,641.5-1,968.3-1,119.8-1,035.8-860.6-745.8-578.6-420.8-320.8-274.2-221.8-193.1
Comprehensive Income-0.9-0.91.4-5.2-1.40.5-0.1-1.4-0.8-0.4-0.4-0.10.10.10.00.0
Total Common Equity3,192.42,402.23,145.33,043.23,387.62,823.52,288.1680.9520.4335.3326.9289.0135.398.683.579.8
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock1.91.91.91.91.91.81.81.81.81.8
Retained Earnings-4,620.0-4,600.4-4,599.2-4,498.0-3,633.4-3,595.2-3,579.4-3,469.2-3,419.4-3,420.2
Comprehensive Income3.23.11.0-0.94.6-0.9-0.51.4-1.5-0.7
Total Common Equity2,501.42,469.42,396.92,402.23,210.53,192.43,132.63,145.33,121.23,056.6
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt2,783.92,754.82,554.72,446.92,362.41,464.2946.3688.84.34.64.91.01.41.71.01.0
Book Value3,192.42,402.23,145.33,043.23,387.62,823.52,288.1680.9520.4335.3326.9289.0135.398.683.579.8
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value2,501.42,469.42,396.92,402.23,210.53,192.43,132.63,145.33,121.23,056.6
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-175.0-207.9-1,028.9-204.1-623.5-595.6-848.5-84.0-175.1-114.4-167.2-157.8-100.0-46.5-52.4-28.7-11.6
Depreciation & Amortization213.4221.6214.9206.6197.6180.3163.450.223.115.611.57.83.71.41.00.40.2
Stock-Based Compensation237.4217.7214.9231.3206.8253.1152.9108.560.335.523.718.111.57.75.54.32.2
Change Working Capital-76.9121.8-56.0-0.3-26.4111.1-42.7-53.6-0.9-7.71.5-1.83.31.54.20.20.8
Change In Accounts Receivable-83.8-48.9-46.3-43.461.125.2-100.5-27.9-17.3-17.5-3.6-3.6-1.40.00.00.00.0
Change In Accounts Payable16.1214.043.582.8-52.2153.146.4-0.611.315.4-2.60.71.9-2.92.9-0.30.9
Change In Inventories4.9-3.8-34.9-7.7-13.2-9.2-30.3-19.0-12.7-19.2-0.2-2.7-4.00.00.00.00.0
Other Non-cash Items61.5139.9875.8-76.433.8202.0721.348.926.2-0.6-0.3-0.5-0.3-4.1-3.0-28.60.1
Cash from Operations118.70.00.0156.1-223.6-102.2136.5-115.0-69.3-71.7-130.1-134.0-80.9-39.3-44.2-27.8-13.5
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-86.0-19.6-1.2-101.2-864.6-38.2-15.8-110.2-49.80.8
Depreciation & Amortization56.455.955.354.153.154.853.053.954.252.3
Stock-Based Compensation0.051.655.854.649.248.856.660.458.661.9
Change Working Capital37.8120.2-34.4-1.8-21.544.429.2-108.226.7-24.6
Change In Accounts Receivable7.346.9-73.0-30.115.2-0.5-23.4-37.5-3.1-19.8
Change In Accounts Payable48.967.10.00.00.00.00.00.031.72.3
Change In Inventories-1.46.75.1-14.2-25.4-9.61.2-1.15.4-0.5
Other Non-cash Items144.511.313.526.2842.729.4-16.420.0-19.4-65.0
Cash from Operations0.00.00.00.00.00.00.00.069.524.4
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-133.6-134.7-136.0-124.2-214.5-135.8-64.4-171.8-150.7-69.2-14.9-22.0-12.5-9.3-0.7-2.1-0.6
Acquisitions-63.0-75.0-45.0-69.0-57.5-517.8-22.6-973.9-17.9-6.00.21.9-0.20.00.10.00.0
Investments-414.1-195.8-466.8-139.9-131.5-1,164.1-1,090.0-634.1-1,192.5-357.1-190.0-205.1-209.5-98.5-96.0-87.0-24.5
Sales of Investment192.5572.3205.8383.0453.1794.3886.71,660.6579.2271.5193.3162.3104.272.358.446.110.2
Other Investing Activities-110.70.00.0-0.324.5-58.8-411.8-1.90.00.0-0.2-1.90.20.0-0.10.00.0
Cash from Investing-418.30.00.049.774.1-1,082.1-702.0-121.1-781.9-160.8-11.5-64.8-117.8-35.5-38.3-43.0-14.9
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-31.2-29.9-42.3-31.2-36.3-26.2-35.9-37.6-34.9-25.2
Acquisitions-75.00.00.00.00.00.00.0-0.2-22.0-40.8
Investments-4.4-96.8-14.3-80.3-60.5-81.1-147.9-177.3-64.8-24.4
Sales of Investment201.840.1252.977.654.970.636.444.054.957.2
Other Investing Activities0.00.00.00.00.00.00.00.00.50.3
Cash from Investing0.00.00.00.00.00.00.00.0-66.8-33.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-404.70.00.0138.00.0-23.7-150.1-493.4-4.8-0.2-0.2-0.4-0.4-0.3-0.10.00.0
Debt Issued708.62,754.8200.0245.884.5922.0667.9750.8689.4-0.2-0.14.30.00.00.81.01.0
Issuance of Common Stock-88.80.00.031.56.50.0861.70.04.3253.4144.2174.1238.673.357.827.282.3
Repurchase of Common Stock28.30.00.028.325.523.118.48.44.92.82.11.70.80.00.00.00.0
Dividends Paid0.00.00.00.00.00.0-18.40.0-929.8-5.1-2.1-1.7-0.80.00.00.00.0
Other Financing Activities-53.00.00.021.844.59.21,168.0738.11,859.510.05.58.05.81.32.40.72.9
Cash from Financing231.70.00.0159.876.58.51,879.6253.2934.1261.0149.6181.8244.074.360.027.985.2
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued2,535.113.60.2-233.5-3.6-3.2206.40.573.41.3
Issuance of Common Stock0.00.00.00.00.00.00.00.0-109.31.1
Repurchase of Common Stock0.00.00.00.00.00.00.00.028.30.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.010.00.1
Cash from Financing0.00.00.00.00.00.00.00.010.00.1
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-70.2349.4-3.0366.9-73.0-1,175.81,314.117.182.928.67.8-17.045.3-0.5-22.4-43.056.8
Closing Cash Balance530.2956.0606.6609.7242.8315.81,491.6177.5160.477.548.941.158.112.913.335.878.8
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash167.0131.9310.0-259.512.058.7184.2-257.914.8-9.8
Closing Cash Balance956.0789.0657.1347.1606.6594.7536.0351.8609.7594.9
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-15.0356.874.531.9-438.0-238.072.1-286.8-220.0-141.0-144.9-156.0-93.4-48.6-44.8-29.9-14.1
Real Free Cash Flow-252.4139.1-140.3-199.4-644.8-491.1-80.8-395.3-280.3-176.5-168.6-174.1-105.0-56.3-50.3-34.2-16.4
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow120.4190.046.7-0.410.7112.671.2-120.034.6-0.8
Real Free Cash Flow120.4138.4-9.1-55.0-38.563.814.6-180.3-24.0-62.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-95.7-32.463
P/S6.1111.457.8
P/B8729.8
P/FCF102.2-41.2549.4
Market cap$12.6$9.9
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %20.2 %0 %
Debt to Income-1219.1 %-304.1 %0 %
Debt to Free cash flow1301.7 %-1935.2 %0 %
Interest expense percentage-18.3 %-6 %2.9 %
Current ratio2.7 8.3 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-8.3 %-29.1 %0 %
ROA-3.5 %-21.5 %0 %
CapEx to Revenue4.1 %70.5 %0 %
RaD to Revenue0 %254.6 %0 %
ROEM463,855.7 31670.2

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin69.7 %69.8 %47.8 %
Operating margin-6.2 %-526.2 %28 %
Net margin-6.4 %-522 %19.8 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.7 %0 %
Dividend payout percentage0 %-34.5 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding189.7 mil 122.0 mil
Employee count7.0 tis 1.6 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader